ABBV
AbbVie Inc.
Stock
$263.29−2.99 (−1.12%)Close Sep 29, 2026
| Stock-based compensation (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $976M | +4.5% | 4.9% | 13.0% |
| Stock-based compensation (TTM) | $976M |
|---|---|
| YoY | +4.5% |
| 5-year CAGR | 4.9% |
| 10-year CAGR | 13.0% |
Stock-based compensation
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $955M | +4.8% |
| 2024 | $911M | +22.0% |
| 2023 | $747M | +11.3% |
| 2022 | $671M | −3.0% |
| 2021 | $692M | −8.1% |
| 2020 | $753M | +75.1% |
| 2019 | $430M | +2.1% |
| 2018 | $421M | +15.3% |
| 2017 | $365M | +3.4% |
| 2016 | $353M | +25.2% |
| 2015 | $282M | +17.0% |
| 2014 | $241M | +13.7% |
| 2013 | $212M | +13.4% |
| 2012 | $187M | +14.7% |
| 2011 | $163M | — |